SCHEMBL20283307

SCHEMBL20283307

CC(C)(C)OC(=O)N1CCOc2ccc(Cl)nc2C1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ABHD6 Q9BV23 1/20 0.42
ESR2 Q92731 1/20 0.42
POLB P06746 1/20 0.40
RIPK1 Q13546 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NR1H2 P55055 2/20 0.39
MAPK1 P28482 1/20 0.39
SCD5 Q86SK9 1/20 0.39
PARP1 P09874 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
MAPT P10636 2/20 0.38
GPR119 Q8TDV5 1/20 0.38
USP30 Q70CQ3 1/20 0.37
MTOR P42345 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20283410 0.87 USP2 (0.43) USP2SMN1; SMN2ESR2RIPK1NR1H2
SCHEMBL30850027 0.87 USP2 (0.43) USP2SMN1; SMN2ESR2RIPK1NR1H2
SCHEMBL22743890 0.83 CKS1B (0.44) USP2SMN1; SMN2ESR2MEN1KMT2A
SCHEMBL30098007 0.81 ESR2 (0.50) USP2SMN1; SMN2ABHD6ESR2POLB
SCHEMBL2891547 0.81 ESR2 (0.50) USP2SMN1; SMN2ABHD6ESR2POLB
SCHEMBL28627169 0.81 ABHD6 (0.40) ABHD6POLBRIPK1MEN1KMT2A
SCHEMBL30419519 0.80 ABHD6 (0.63) ABHD6ESR2POLBMEN1KMT2A
SCHEMBL868119 0.80 ABHD6 (0.63) ABHD6ESR2POLBMEN1KMT2A
SCHEMBL20281224 0.80 POLB (0.48) USP2SMN1; SMN2ESR2POLBNR1H2
SCHEMBL30850017 0.79 NR1H2 (0.46) ABHD6ESR2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118206566-A Hydroxypyridooxazepine as NRF2 activator 葛兰素史密斯克莱知识产权发展有限公司 2024-06-18 CN disclosed
CN-113474349-B Hydroxypyridooxazepine as NRF2 activator 葛兰素史密斯克莱知识产权发展有限公司 2024-03-01 CN disclosed
EP-3555082-B1 ETHER LINKED TRIAZOLES AS NRF2 REGULATORS GLAXOSMITHKLINE IP DEV LTD (GB) 2022-01-26 EP disclosed
WO-2020241853-A1 BENZOTRIAZOLE DERIVATIVE 宇部興産株式会社 2020-12-03 WO disclosed
WO-2018109649-A1 ETHER LINKED TRIAZOLES AS NRF2 REGULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-06-21 WO disclosed